Two Seas Capital »

Nektar Therapeutics shares owned by Two Seas Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $32M 745k 42.28

More positions owned by Two Seas Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Core Scientific (CORZ)
Roivant Sciences SHS (ROIV)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Indivior Ord
Calumet (CLMT)
Talen Energy Corp (TLN)
Hut 8 Corp (HUT)
Sotera Health (SHC)
Gannett (TDAY)
First Solar (FSLR)
Immunovant (IMVT)
Arbutus Biopharma (ABUS)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Terawulf (WULF)

View all positions for Two Seas Capital

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics